SK34894A3 - Solution of sparfloxacine, the method of its preparation and sparfloxacine salt - Google Patents

Solution of sparfloxacine, the method of its preparation and sparfloxacine salt Download PDF

Info

Publication number
SK34894A3
SK34894A3 SK348-94A SK34894A SK34894A3 SK 34894 A3 SK34894 A3 SK 34894A3 SK 34894 A SK34894 A SK 34894A SK 34894 A3 SK34894 A3 SK 34894A3
Authority
SK
Slovakia
Prior art keywords
acid
sparfloxacin
monocarboxylic
solution
solution according
Prior art date
Application number
SK348-94A
Other languages
English (en)
Slovak (sk)
Inventor
Guillaume Conrath
Original Assignee
Rhone Dpc Europ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Dpc Europ filed Critical Rhone Dpc Europ
Publication of SK34894A3 publication Critical patent/SK34894A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SK348-94A 1991-09-27 1992-09-25 Solution of sparfloxacine, the method of its preparation and sparfloxacine salt SK34894A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9111913A FR2681863B1 (fr) 1991-09-27 1991-09-27 Solution de sparfloxacine sa preparation et sel la constituant.
PCT/FR1992/000891 WO1993005782A1 (fr) 1991-09-27 1992-09-25 Sels de sparfloxacine et solutions les contenant

Publications (1)

Publication Number Publication Date
SK34894A3 true SK34894A3 (en) 1994-08-10

Family

ID=9417358

Family Applications (1)

Application Number Title Priority Date Filing Date
SK348-94A SK34894A3 (en) 1991-09-27 1992-09-25 Solution of sparfloxacine, the method of its preparation and sparfloxacine salt

Country Status (22)

Country Link
US (1) US5478829A (de)
EP (2) EP0605646B1 (de)
JP (1) JPH07503941A (de)
AT (1) ATE168008T1 (de)
AU (1) AU671602B2 (de)
CA (1) CA2119270A1 (de)
CZ (1) CZ69494A3 (de)
DE (1) DE69226192D1 (de)
FI (1) FI941399A0 (de)
FR (1) FR2681863B1 (de)
HU (1) HUT67672A (de)
IL (1) IL103270A (de)
MX (1) MX9205461A (de)
NO (1) NO941036L (de)
NZ (1) NZ244479A (de)
PL (2) PL170495B1 (de)
SG (1) SG59982A1 (de)
SK (1) SK34894A3 (de)
TW (1) TW202393B (de)
WO (1) WO1993005782A1 (de)
YU (1) YU86792A (de)
ZA (1) ZA927330B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5103898A (en) * 1996-11-05 1998-05-29 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
EP1685843A1 (de) * 1999-06-30 2006-08-02 Ruey J. Dr. Yu Oligosaccharidealdonsäure und ihre topische Verabreichung
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE19962353A1 (de) 1999-12-23 2001-07-05 Henkel Ecolab Gmbh & Co Ohg Hepatitis A Viruzid
US6979471B1 (en) * 2000-09-05 2005-12-27 Council Of Scientific And Industrial Research Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra
WO2003015752A1 (en) * 2001-08-14 2003-02-27 Bakulesh Mafatlal Khamar The process for preparing isotonic topical antibiotic ophthalmic formulation with improved therapeutic effect
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
WO2008114861A1 (ja) * 2007-03-22 2008-09-25 Daiichi Sankyo Company, Limited アルコール類含有キノロン医薬組成物
EP2712611A1 (de) * 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilisierte wässrige Zusammensetzungen von neuromuskulären Blockiermitteln

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤

Also Published As

Publication number Publication date
YU86792A (sh) 1995-10-03
ZA927330B (en) 1993-04-21
DE69226192D1 (de) 1998-08-13
MX9205461A (es) 1993-03-01
FI941399A7 (fi) 1994-03-25
HUT67672A (en) 1995-04-28
EP0605646B1 (de) 1998-07-08
FR2681863B1 (fr) 1995-02-03
AU671602B2 (en) 1996-09-05
AU2772292A (en) 1993-04-27
EP0605646A1 (de) 1994-07-13
NO941036D0 (no) 1994-03-22
EP0534860A1 (de) 1993-03-31
FR2681863A1 (fr) 1993-04-02
ATE168008T1 (de) 1998-07-15
WO1993005782A1 (fr) 1993-04-01
FI941399L (fi) 1994-03-25
IL103270A0 (en) 1993-02-21
CA2119270A1 (fr) 1993-04-01
FI941399A0 (fi) 1994-03-25
US5478829A (en) 1995-12-26
TW202393B (de) 1993-03-21
IL103270A (en) 1996-11-14
PL170495B1 (en) 1996-12-31
NZ244479A (en) 1995-04-27
CZ69494A3 (en) 1994-07-13
JPH07503941A (ja) 1995-04-27
NO941036L (no) 1994-03-22
SG59982A1 (en) 1999-02-22
PL170357B1 (en) 1996-12-31
HU9400868D0 (en) 1994-06-28

Similar Documents

Publication Publication Date Title
US4081528A (en) Tetracycline compositions
SK34894A3 (en) Solution of sparfloxacine, the method of its preparation and sparfloxacine salt
GB1563478A (en) Tetracycline antibiotic compositions
US4942167A (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
US5169847A (en) Drug solutions of increased stability and without tissue-damaging effect and process for preparing same
PL182095B1 (pl) Roztwory do iniekcji lub wlewów PL PL PL PL PL PL PL PL PL
US4081527A (en) Chlortetracycline compositions
US4780465A (en) Aqueous solution containing a quinolone carboxylic acid
EP0356143B1 (de) Injektionslösungen
DE60307086T2 (de) Zusammensetzng auf diclofenac-basis für die topische behandlung von erkrankungen des oropharynx
ES2272092T3 (es) Soluciones farmaceuticas que comprenden antiestrogenos de triofeniletileno.
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
US5034397A (en) Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
EP1807112B1 (de) Stabile wässrige formulierungen eines platin derivats
US6451302B1 (en) Parenteral water-miscible non-intensely colored injectable composition of non-steroidal anti-inflammatory drugs
WO2006126825A1 (en) Composition comprising tetrafluorobenzyl derivatives or salts of thereof for injection
DE60109889T2 (de) Stabile wässrige lösung von deoxyfructosazine
RU2238720C1 (ru) Фармацевтический водный раствор для инъекций
KR0138104B1 (ko) 6-(3-디메틸아미노프로피오닐) 포르스콜린의 동결 건조 제제
JPH0478612B2 (de)
KR100486089B1 (ko) 암프롤륨, 설파퀴녹살린, 및 에토파베이트를 함유하는액상제제의 제조방법
KR900000746B1 (ko) 주사제용 세파만돌 나페이트 제제의 안정화 방법
HU211580A9 (hu) Megnövelt stabilitású, szövetkárosító hatás nélküli piroxikam-oldatok Az átmeneti oltalom az 1., 2., 5. és 6. igénypontokra vonatkozik.
FI72651B (fi) Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfametazin.
JPH05262650A (ja) 安定な注射用組成物